XML 54 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
EMPLOYEE STOCK COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Share-Based Compensation Expense
The following table presents share-based compensation expense and the related tax benefits for the periods indicated:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
Stock options
$
420

 
$
159

 
$
667

 
$
297

Restricted stock awards and units
4,378

 
1,741

 
6,982

 
5,394

Stock appreciation rights

 
2

 
42

 
15

Total share-based compensation expense
$
4,798

 
$
1,902

 
$
7,691

 
$
5,706

Related tax benefits
$
1,992

 
$
790

 
$
3,195

 
$
2,371

Unrecognized Share-Based Compensation Expense
The following table presents unrecognized share-based compensation expense as of June 30, 2017:
 
June 30, 2017
 
Unrecognized
Expense
 
Weighted-Average
Remaining Expected
Recognition Period
 
($ in thousands)
Stock option awards
$
786

 
3.1 years
Restricted stock awards and restricted stock units
13,541

 
2.6 years
Total
$
14,327

 
2.7 years
Option Activity
The following table represents stock option activity as of and for the three months ended June 30, 2017:
 
Three Months Ended June 30, 2017
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
 
Weighted-Average
Remaining Contract Term
 
Aggregated
Intrinsic Value
(In thousands)
Outstanding at beginning of period
877,591

 
$
14.14

 
6.5 years
 
$
5,755

Granted

 
$

 

 


Exercised
(40,786
)
 
$
12.41

 
6.9 years
 


Forfeited
(96,000
)
 
$
17.50

 
8.8 years
 


Outstanding at end of period
740,805

 
$
13.80

 
7.1 years
 
$
5,702

Exercisable at end of period
475,075

 
$
13.33

 
6.6 years
 
$
3,881

The following table represents stock option activity as of and for the six months ended June 30, 2017:
 
Six Months Ended June 30, 2017
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
 
Weighted-Average
Remaining Contract Term
 
Aggregated
Intrinsic Value
(In thousands)
Outstanding at beginning of period
968,591

 
$
13.95

 
6.4 years
 
$
3,336

Granted

 
$

 

 
 
Exercised
(131,786
)
 
$
12.17

 
9.7 years
 
 
Forfeited
(96,000
)
 
$
17.50

 
8.8 years
 
 
Outstanding at end of period
740,805

 
$
13.80

 
7.1 years
 
$
5,702

Exercisable at end of period
475,075

 
$
13.33

 
6.6 years
 
$
3,881

Nonvested Share
The following table represents changes in unvested stock options as of and for the three and six months ended June 30, 2017:
 
Three Months Ended
 
Six Months Ended
 
June 30, 2017
 
June 30, 2017
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
Outstanding at beginning of period
513,338

 
$
15.07

 
518,936

 
$
15.04

Vested
(151,608
)
 
$
14.26

 
(157,206
)
 
$
14.22

Forfeited
(96,000
)
 
$
17.50

 
(96,000
)
 
$
17.50

Outstanding at end of period
265,730

 
$
14.65

 
265,730

 
$
14.65

Restricted Stock and Restricted Stock Units Activity
The following table represents unvested restricted stock awards and restricted stock units activity as of and for the three and six months ended June 30, 2017:
 
Three Months Ended
 
Six Months Ended
 
June 30, 2017
 
June 30, 2017
 
Number of Shares
 
Weighted Average
Grant Date Fair Value
Per Share
 
Number of Shares
 
Weighted Average
Grant Date Fair Value
Per Share
Outstanding at beginning of period
1,056,421

 
$
15.43

 
1,417,144

 
$
16.16

Granted
633,226

 
$
20.74

 
633,226

 
$
20.74

Vested
(414,106
)
 
$
16.25

 
(716,948
)
 
$
17.39

Forfeited
(225,227
)
 
$
17.85

 
(283,108
)
 
$
17.24

Outstanding at end of period
1,050,314

 
$
17.85

 
1,050,314

 
$
17.85


Summary of all Outstanding SARs
The following table represents SARs activity as of and for the three months ended June 30, 2017:
 
Three Months Ended June 30, 2017
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
 
Weighted-Average
Remaining Contract Term
 
Aggregated
Intrinsic Value
(In thousands)
Outstanding at beginning of period
1,559,012

 
$
11.60

 
5.4 years
 
$
14,183

Outstanding at end of period
1,559,012

 
$
11.60

 
5.1 years
 
$
15,430

Exercisable at end of period
1,559,012

 
$
11.60

 
5.1 years
 
$
15,430

The following table represents SARs activity as of and for the six months ended June 30, 2017:
 
Six Months Ended June 30, 2017
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
 
Weighted-Average
Remaining Contract Term
 
Aggregated
Intrinsic Value
(In thousands)
Outstanding at beginning of period
1,559,047

 
$
11.60

 
5.6 years
 
$
8,961

Forfeited
(35
)
 
$
10.09

 
5.1 years
 
 
Outstanding at end of period
1,559,012

 
$
11.60

 
5.1 years
 
$
15,430

Exercisable at end of period
1,559,012

 
$
11.60

 
5.1 years
 
$
15,430

The following table represents changes in unvested SARs as of and for the three and six months ended June 30, 2017:
 
Three Months Ended
 
Six Months Ended
 
June 30, 2017
 
June 30, 2017
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
Outstanding at beginning of period

 
$

 
8,069

 
$
10.09

Vested

 
$

 
(8,034
)
 
$
10.09

Forfeited

 
$

 
(35
)
 
$
10.09

Outstanding at end of period

 
$

 

 
$